Myelofibrosis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

International team identifies genetic model for predicting primary ... - EurekAlert (press release)



International team identifies genetic model for predicting primary ... 
EurekAlert (press release)
A group of investigators from Mayo Clinic and multiple academic research centers in Italy have identified a genetic model for predicting outcomes in patients with primary myelofibrosis who are 70 years or younger and candidates for stem cell transplant ...

and more » 


Sotatercept Effective in Improving Anemia in Patients with MPN-Associated Myelofibrosis - Rare Disease Report



Rare Disease Report
 
Sotatercept Effective in Improving Anemia in Patients with MPN-Associated Myelofibrosis 
Rare Disease Report
MPN-associated myelofibrosis is characterized by a shortage in red blood cells, or anemia, in almost all affected persons. Current treatment options are unsatisfactory, and anemia is notoriously worsened by ruxolitinib, the only U.S. Food and Drug (FDA ...

 


Myelofibrosis (MF) Industry Overview with Total Market Share and Distribution of Myelofibrosis (MF) for 7 MM for 2025 - MilTech



Myelofibrosis (MF) Industry Overview with Total Market Share and Distribution of Myelofibrosis (MF) for 7 MM for 2025 
MilTech
?Myelofibrosis (MF) ? Market Insights, Epidemiology and Market Forecast ? 2025? report provides an overview of the disease and in depth research related to Myelofibrosis (MF) for the 7MM (United States, Germany, France, Italy, Spain and UK) for the ...

and more » 


Key Factors to Fuel Growth of the Myelofibrosis Market through 2016 ? 2024 - MilTech



Key Factors to Fuel Growth of the Myelofibrosis Market through 2016 ? 2024 
MilTech
Presently there are numerous research projects under examination that are concentrating on developing specific treatment for myelofibrosis. CTI BioPharma is studying oral pacritinib usage in myelofibrosis treatment, a molecule ? CYT387 is being ...

and more » 


Myelofibrosis Industry-Epidemiology Dynamics, Segments ,Forecast to 2025 - Medgadget (blog)



Myelofibrosis Industry-Epidemiology Dynamics, Segments ,Forecast to 2025 
Medgadget (blog)
?Myelofibrosis -Epidemiology Forecast, 2025? provides an overview of the epidemiology trends of Myelofibrosis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of ...

and more » 


New report on Myelofibrosis (MF) Industry- Epidemiology Forecast To 2025 - Medgadget (blog)



New report on Myelofibrosis (MF) Industry- Epidemiology Forecast To 2025 
Medgadget (blog)
?Myelofibrosis (MF) ? Epidemiology Forecast To 2025? provides an overview of the epidemiology trends of Myelofibrosis (MF) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and ...

 


2 Reasons Geron Corporation Took a Pounding in November - Motley Fool



Madison.com
 
2 Reasons Geron Corporation Took a Pounding in November 
Motley Fool
Risk factors in the company's 10-Q filing with the Securities and Exchange Commission paints a pretty grim picture of what could happen to Geron financially if it's forced to move forward with imetelstat's development while relying on its own wallet ...
Geron: It's Breakout Time Seeking Alpha

all 14 news articles » 


Expert Discusses Guidelines, Next Steps With MPNs - OncLive



OncLive
 
Expert Discusses Guidelines, Next Steps With MPNs 
OncLive
There are important, randomized, phase III, high-quality studies comparing this class of medications to hydroxyurea. Having evidence to decide on first-line therapy is important for PV. Second-line therapies are well defined. With ruxolitinib (Jakafi ...

 


Myelofibrosis Pipeline Overview 2017 Market Insights and Epidemiology - Medgadget (blog)



Myelofibrosis Pipeline Overview 2017 Market Insights and Epidemiology 
Medgadget (blog)
RnRMarketResearch.com announces a new report ?Myelofibrosis Pipeline Insights, 2017? added to its Pharmaceuticals business research collection of its growing online library. ?Myelofibrosis Pipeline Insights, 2017?, report provides comprehensive ...

and more » 


Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Attractiveness, Competitive Landscape and Key ... - Newsient (blog)



Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Attractiveness, Competitive Landscape and Key ... 
Newsient (blog)
Questale published a new in-depth industry research that focuses on Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market, delivers detailed analysis of market and future prospects of Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market ...